LicenseTheData.comA field guide to business-data licensing
Home/Comparisons

Public evidence · 13 October 2026

micro1 vs Protege

Direct licensing meets specialist licensing. Neither advertised amounts nor a public seller route establish what your business will receive.

Jump to the terms ledger ↓

Research comparison; limited public terms. Pair-level evidence and scenario review is pending. Published fields alone do not meet our indexing threshold. This page is noindex and absent from the sitemap, not a negative verdict.

The terms ledger.

Headquarters or contact location is not seller eligibility. Response, acceptance and payout stages are not interchangeable.

Published descriptions and unresolved contract terms
Criterionmicro1Protege
Operating recordsPublished
SOPs, knowledge bases, CRM, projects, QA and internal processes
Source ↗
Published
Healthcare, video, audio/speech, spatial/physical and other domains; generic CRM/SOP archives not explicitly enumerated
Source ↗
Company eligibilityPublished
30+ employees; established documentation; English documents and representatives.
Source ↗
Published
Typically owns outright or controls broad global/all-media rights; quality and opportunity-specific qualification.
Source ↗
Seller geographyPublished
US prioritized, then Western markets; strongest current demand US/UK/Canada. Global referrals do not mean global acceptance.
Source ↗
Unknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Published compensationProvider claim
$100k+, $500k+, $1M+ advertised partnership tiers. USD context; period unspecified; individually evaluated, not guaranteed.
Source ↗
Provider claim
Negotiated revenue share. Gradient Health seven-figure revenue is a provider-hosted specialist case, not an ordinary business rate.
Source ↗
Fees & net proceedsUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Unknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Timeline & payment triggerUnknown
Not published / not established
Not established in inspected sources: No quantified payment timeline published. Ask the provider; missing terms do not establish acceptance, free fees or a payment deadline. Inspection URLs remain in the profile source list.
Provider claim
Active opportunities often fulfilled under a month; fulfillment is not seller payment timing.
Source ↗
Preparation & seller effortPublished
Evaluation → discovery → agreed requirements → partnership.
Source ↗
Published
Discovery → revenue-share agreement → curate/QA/mask → qualified deal → revenue-share payment.
Source ↗
Ownership & permitted usePublished
Retains underlying ownership; approvals and scope agreed before participation.
Source ↗
Published
Retains ownership; limited defined AI training/fine-tuning/evaluation/benchmarking rights; no public exhibition/redistribution/entertainment use.
Source ↗
Privacy & approvalProvider claim
PII removed when relevant; samples reviewable; isolated processing and authorized access.
Source ↗
Provider claim
Identifier removal and jurisdiction-specific workflows; optional anonymization/voice modification. Media FAQ is not a universal operating-data contract.
Source ↗
ExclusivityUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Unknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Retention & deletionPublished
Retention/deletion follow agreed terms; no public exact duration.
Source ↗
Unknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
HQ / published contactPublished
Published privacy contact: San Francisco, US; operational HQ not independently established.
Source ↗
Published
Published contact: New York, NY, US; not independently verified operational HQ.
Source ↗

Operating records

micro1Published
SOPs, knowledge bases, CRM, projects, QA and internal processes
Source ↗
ProtegePublished
Healthcare, video, audio/speech, spatial/physical and other domains; generic CRM/SOP archives not explicitly enumerated
Source ↗

Company eligibility

micro1Published
30+ employees; established documentation; English documents and representatives.
Source ↗
ProtegePublished
Typically owns outright or controls broad global/all-media rights; quality and opportunity-specific qualification.
Source ↗

Seller geography

micro1Published
US prioritized, then Western markets; strongest current demand US/UK/Canada. Global referrals do not mean global acceptance.
Source ↗
ProtegeUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.

Published compensation

micro1Provider claim
$100k+, $500k+, $1M+ advertised partnership tiers. USD context; period unspecified; individually evaluated, not guaranteed.
Source ↗
ProtegeProvider claim
Negotiated revenue share. Gradient Health seven-figure revenue is a provider-hosted specialist case, not an ordinary business rate.
Source ↗

Fees & net proceeds

micro1Unknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
ProtegeUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.

Timeline & payment trigger

micro1Unknown
Not published / not established
Not established in inspected sources: No quantified payment timeline published. Ask the provider; missing terms do not establish acceptance, free fees or a payment deadline. Inspection URLs remain in the profile source list.
ProtegeProvider claim
Active opportunities often fulfilled under a month; fulfillment is not seller payment timing.
Source ↗

Preparation & seller effort

micro1Published
Evaluation → discovery → agreed requirements → partnership.
Source ↗
ProtegePublished
Discovery → revenue-share agreement → curate/QA/mask → qualified deal → revenue-share payment.
Source ↗

Ownership & permitted use

micro1Published
Retains underlying ownership; approvals and scope agreed before participation.
Source ↗
ProtegePublished
Retains ownership; limited defined AI training/fine-tuning/evaluation/benchmarking rights; no public exhibition/redistribution/entertainment use.
Source ↗

Privacy & approval

micro1Provider claim
PII removed when relevant; samples reviewable; isolated processing and authorized access.
Source ↗
ProtegeProvider claim
Identifier removal and jurisdiction-specific workflows; optional anonymization/voice modification. Media FAQ is not a universal operating-data contract.
Source ↗

Exclusivity

micro1Unknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
ProtegeUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.

Retention & deletion

micro1Published
Retention/deletion follow agreed terms; no public exact duration.
Source ↗
ProtegeUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.

HQ / published contact

micro1Published
Published privacy contact: San Francisco, US; operational HQ not independently established.
Source ↗
ProtegePublished
Published contact: New York, NY, US; not independently verified operational HQ.
Source ↗

Which difference matters to your company?

Rights fit

For specialist healthcare or media rights, Protege's published categories and Gradient Health case are more relevant than ordinary CRM exports. micro1 lists SOPs, knowledge bases, CRM, projects, QA and internal processes. Do not extrapolate specialist case revenue to a small operating business.

micro1: source 1 ↗ source 2 ↗ source 3 ↗ Protege: source 1 ↗ source 2 ↗ source 3 ↗ Public descriptions, not tested seller outcomes.

Payment trigger

micro1: Payment timing not established; ask the provider. Protege: Active opportunities often fulfilled under a month; fulfillment is not seller payment timing. These clocks measure different stages, not equivalent payout deadlines; ask for a written acceptance-to-payment interval.

micro1: Protege: source 1 ↗ source 2 ↗ source 3 ↗ Public descriptions, not tested seller outcomes.

Shared diligence, not shared guarantees.

Both routes need lawful rights to the material. Removing names does not remove confidentiality obligations or re-identification risk. Require sample approval, buyer-use restrictions, precise payment triggers and downstream retention/deletion terms.

Seller-outcome evidence

micro1: No independently audited operating-business payout established in this research. Provider cases and partnership confirmations do not establish a typical seller outcome.

Protege: Gradient Health seller-hosted announcement corroborates partnership and imaging supply, not revenue. Provider-hosted case claims seven-figure revenue; no independently audited receipt.

Put two routes side by side.

Choose two different providers. No income ranking.

Sources & unknowns.

Source claims were inspected on 13 October 2026. No intake was submitted or transaction tested. Unknowns are not zero fees, universal eligibility or unrestricted rights.

Read the evidence and indexing methodology →